Immunoblot assay in differential diagnosis of autoimmune blistering skin diseases

Clinics in Dermatology

Volumn 19, Issue 5, 2001, Pages 622-630

  Pas, Hendri H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN;

AUTOIMMUNE DISEASE; BULLOUS SKIN DISEASE; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MUCOUS MEMBRANE PEMPHIGOID; NONHUMAN; PEMPHIGOID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN TRANSPORT; REVIEW; SOLUBILIZATION;

EID: 0034816728     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(00)00176-0     Document Type: Article

References (79)

1. Bullous pemphigoid antigens; extraction and degradation of antigens during epidermal preparation
2. Tissue form of type VII collagen from human skin and dermal fibroblasts in culture
3. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
4. An extract from cultured human keratinocytes that contains the major autoantigens related to autoimmune bullous skin diseases
5. Cylindroma overexpresses collagen VII, the major anchoring fibril protein
6. Bullous pemphigoid; Serum antibody titre and antigen specificity
7. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1
8. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile
9. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris
10. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins
11. Desmocollins I and II are recognized by certain sera from patients with various types of pemphigus, particularly Brazilian pemphigus foliaceus
12. Identification of a new antibody population directed against a desmosomal plaque antigen in pemphigus vulgaris and pemphigus foliaceus
13. Pemphigus vulgaris antibody identifies pemphaxin-A novel keratinocyte annexin-like molecule binding acetylcholine
14. Paraneoplastic pemphigus An autoimmune mucocutaneous disease associated with neoplasia
15. Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis
16. Human desmocollin 1 (Dsc1) is an autoantigen for the subcorneal pustular dermatosis type of IgA pemphigus
17. Nonsecretory IgA1 autoantibodies targeting desmosomal component desmoglein 3 in intraepidermal neutrophilic IgA dermatosis
18. Bullous pemphigoid and linear IgA dermatosis sera recognize a similar 120-kDa keratinocyte collagenous glycoprotein with antigenic cross-reactivity to BP180
19. Bullous pemphigoid sera that contain antibodies to BPAg2 also contain antibodies to LABD97 that recognize epitopes distal to the NC16A domain
20. The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases
21. The 120-kDa soluble ectodomain of type XVII collagen is recognized by autoantibodies in patients with pemphigoid and linear IgA dermatosis
22. A case of subepidermal blister disease associated with autoantibody against 450 kD protein
23. A vesicular bullous pemphigoid with an autoantibody against plectin
24. A 230-kD basic protein is the major bullous pemphigoid antigen
25. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid
26. Anti-BP180 autoantibodies as a marker of poor prognosis in bullous pemphigoid; A cohort analysis of 94 elderly patients
27. Herpes gestationis autoantibodies recognize a 180-kD human epidermal antigen
28. Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera Immunolocalization of this protein to the hemidesmosome
29. Western blot analysis of the antigen in pemphigoid gestationis
30. Analysis of antigens recognized by autoantibodies in herpes gestationis. Usefulness of immunoblotting using a fusion protein representing an extracellular domain of the 180 kD bullous pemphigoid antigen
31. The major cicatricial pemphigoid antigen is a 180-kD protein that shows immunologic cross-reactivities with the bullous pemphigoid antigen
32. Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain
33. Analysis of antigens targeted by circulating IgG and IgA autoantibodies in 50 patients with cicatricial pemphigoid
34. Mucous membrane pemphigoid; A dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease
35. Bullous pemphigoid and cicatricial pemphigoid; Immunoblotting detection of involved autoantigens
36. A case of cicatricial pemphigoid with circulating IgA and IgG antibodies directed against 280 kD, 165 kD and 120-130 kD epidermal antigens
37. An acquired bullous dermatosis due to an autoimmune reaction against uncein
38. Identification of a 168-kDa mucosal antigen in a subset of patients with cicatricial pemphigoid
39. Identification of a basement membrane zone antigen reactive with circulating IgA antibody in ocular cicatricial pemphigoid
40. Detection and partial characterization of ocular cicatricial pemphigoid antigens on COLO and SCaBER tumor cell lines
41. Unilateral ocular cicatricial pemphigoid with circulating IgA and IgG autoantibodies reactive with the 180 kD bullous pemphigoid antigen
42. Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis
43. LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells
44. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2
45. Linear IgA bullous dermatosis with IgA antibodies exclusively directed against the 180- or 230-kDa epidermal antigens
46. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP180
47. Linear immunoglobulin A (IgA) bullous dermatosis of childhood; Identification of the target antigens and study of the cellular sources
48. The localization of target antigens and autoantibodies in linear IgA disease is variable; Correlation of immunogold electron microscopy and immunoblotting
49. Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita
50. Bullous systemic lupus erythematosus; An unusual clinical course and detectable circulating autoantibodies to the epidermolysis bullosa acquisita antigen
51. Linear IgA bullous dermatosis with autoantibodies to a 290 kd antigen of anchoring fibrils
52. A case of linear IgA bullous dermatosis with IgA anti-type VII collagen antibodies
53. Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita
54. Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease
55. Antiepiligrin cicatricial pemphigoid. A subepithelial bullous disorder
56. Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5
57. Antiepiligrin cicatricial pemphigoid represents an autoimmune response to subunits present in laminin 5 (alpha3beta3gamma2)
58. Anti-epiligrin cicatricial pemphigoid with IgG autoantibodies to the beta and gamma subunits of laminin 5
59. Anti-epiligrin cicatricial pemphigoid with antibodies against the gamma2 subunit of laminin 5
60. A newly identified 105-kD lower lamina lucida autoantigen is an acidic protein distinct from the 105-kD gamma 2 chain of laminin-5
61. A novel 105-kDa lamina lucida autoantigen; Association with bullous pemphigoid
62. A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone
63. Subepidermal blistering disease with autoantibodies against a novel dermal 200-kDa antigen
64. The alpha 5 chain of type IV collagen is the target of IgG autoantibodies in a novel autoimmune disease with subepidermal blisters and renal insufficiency
65. A monoclonal antibody to the desmosomal glycoprotein desmoglein I binds the same polypeptide as human autoantibodies in pemphigus foliaceus
66. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion
67. Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies
68. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting
69. Four Japanese patients with cicatricial pemphigoid showing both IgG and IgA antibodies against the 180 kDa bullous pemphigoid antigen
70. Identification and partial characterization of a novel 105-kDalton lower lamina lucida autoantigen associated with a novel immune-mediated subepidermal blistering disease
71. Human autoantibodies against HD1/plectin in paraneoplastic pemphigus
72. cDNA cloning of the 210-kDa paraneoplastic pemphigus antigen reveals that envoplakin is a component of the antigen complex
73. The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin
74. Erythema multiforme associated human autoantibodies against desmoplakin I and II; biochemical characterization and passive transfer studies into newborn mice
75. Ocular cicatricial pemphigoid antigen; partial sequence and biochemical characterization
76. Identification of a novel basement membrane antigen (p84) defined by sera with antibodies to both the epidermal and dermal side of split skin
77. A novel bullous pemphigoid antigen (BP125) located in the deeper layers of the basement membrane zone
78. Identification of a new hemidesmosomal protein, HD1; A major, high molecular mass component of isolated hemidesmosomes
79. Defective expression of plectin/HD1 in epidermolysis bullosa simplex with muscular dystrophy